Specialty Dosage Drugs

Oct 02, 2016
Pharmaceutical Technology
This article will equip the excipient vendor with an understanding of QbD from the perspective of the topical pharmaceutical product manufacturer.
Sep 14, 2016
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Sep 02, 2016
By Pharmaceutical Technology Editors
Aptar Pharma has signed a license agreement with BD to jointly develop and bring a new autoinjector to market.
Sep 01, 2016
Pharmaceutical Technology
Analytics and science-based approaches are shedding more light on these complex dosage forms, promising to improve process control and product design.
Jul 18, 2016
By Pharmaceutical Technology Editors
The agency says the increasing requests for orphan drug designation has resulted in a change in FDA’s review goals.
Jun 30, 2016
By Pharmaceutical Technology Editors
The drug received breakthrough therapy and orphan drug designation as a monotherapy for the treatment of chronic graft-versus-host-disease.
Jun 02, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
The company expanded its topicals capacity with an investment in the Becomix RW30 model homogenizer.
May 31, 2016
By Pharmaceutical Technology Editors
The agency publishes draft guidance on assessing the adhesion of transdermal delivery systems and topical patches.
native1_300x100
lorem ipsum